Altimmune Inc (ALT)

EBITDA Margin

0.00%

Quarterly · Period ending:

ALT logo

ALT EBITDA Margin

Latest reported0.00%
ALT Quarterly EBITDA Margin (75.86% → 0.00%)
High-resolution chart · PNG

ALT ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Altimmune Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
0%
0%
-101,753.8462%
-369,840%
-437,040%
-404,520%
-462,920%
-456,040%
-491,560%
-485,720%
-80,402.7027%
-5,669.8895%
-265,633.3333%
-94,985.7143%
19,270.9091%
-1,162,233.4%
-249,862.5%
-66,125%
-653.8818%
-21,007.5943%
-12,203.6496%
-1,659.5465%
-723.2074%
-618.6877%
-2,531.7059%
-247.8155%
-615.1028%
-1,694.0878%
-203.6053%
-65.7244%
-1,046.9263%
-111.1775%
-437.152%
-83,528.1693%
-423.7842%
-683.7646%
-80,772.013%
-380.5323%
-214.2579%
-478.9496%
-73.4353%
-124.7334%
-30.0617%
-90.1274%
-198.3262%
21.8657%
-139.2283%
-469.5628%
-9.6483%
-56.6175%
-117.3979%
-108.4438%
-25.2197%
-16.0326%
-17.9269%
-25.57%
-8.748%
-39.6898%
-15.5506%
-112.2005%
-35.8657%
-30.6513%
-34.2487%
-49.7547%
-110.5239%
-229.7815%
-81.5334%
-106.557%
-81.4052%
-96.3331%
-83.8982%
-31.5915%
95.6149%
-80.6067%
-90.8426%
-101.6003%
100%
-535.1819%
54.6268%
-676.1258%
72.502%
58.6263%
45.1061%
75.8631%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.